US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist

104.770
+0.030+0.03%

Close May 13 16:00 ET

104.580
-0.190-0.18%

Pre 08:38 ET

182.26BMarket Cap32.64P/E (TTM)

Abbott Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-10.32%1.03B

-24.21%7.26B

30.61%3.04B

-32.48%1.88B

-50.08%1.2B

-44.65%1.14B

-9.04%9.58B

-24.16%2.33B

2.92%2.78B

13.25%2.41B

Net income from continuing operations

-7.06%1.23B

-17.45%5.72B

54.31%1.59B

0.07%1.44B

-31.86%1.38B

-46.14%1.32B

-1.95%6.93B

-48.06%1.03B

-31.67%1.44B

69.72%2.02B

Operating gains losses

----

-41.40%126M

----

290.91%215M

----

Depreciation and amortization

-0.12%805M

-0.73%3.24B

0.74%813M

1.10%824M

-2.68%800M

-2.07%806M

-7.66%3.27B

-8.61%807M

-3.78%815M

-5.95%822M

Other non cash items

30.48%-748M

----

-352.11%-179M

-817.39%-660M

-424.88%-1.08B

----

291.89%71M

194.85%92M

Change In working capital

-201.61%-561M

-62.94%-2.48B

-1,436.84%-1.52B

-195.54%-321M

33.13%-444M

85.75%-186M

-97.02%-1.52B

207.55%114M

204.02%336M

-2,313.33%-664M

-Change in receivables

-164.81%-151M

-423.53%-356M

-80.06%68M

-186.98%-461M

-4.26%-196M

131.03%233M

82.25%-68M

280.42%341M

234.52%530M

-637.14%-188M

-Change in inventory

2.15%-410M

83.58%-232M

256.08%295M

172.16%140M

47.90%-248M

24.37%-419M

-209.87%-1.41B

-1,360.00%-189M

-373.24%-194M

-9,420.00%-476M

-Change in prepaid assets

----

-622.67%-542M

----

75.96%-75M

----

-Change in payables and accrued expense

----

-280.95%-760M

----

-67.39%420M

----

-Change in other working capital

----

-52.74%-585M

----

57.82%-383M

----

Cash from discontinued investing activities

Operating cash flow

-10.32%1.03B

-24.21%7.26B

30.61%3.04B

-32.48%1.88B

-50.08%1.2B

-44.65%1.14B

-9.04%9.58B

-24.16%2.33B

2.92%2.78B

13.25%2.41B

Investing cash flow

Cash flow from continuing investing activities

8.01%-425M

-80.06%-3.13B

-30.38%-824M

-30.99%-634M

-359.47%-1.21B

-28.33%-462M

13.35%-1.74B

5.81%-632M

25.65%-484M

0.00%-264M

Net PPE purchase and sale

-4.74%-398M

-23.92%-2.2B

-23.77%-755M

-19.91%-560M

-33.77%-507M

-18.38%-380M

5.73%-1.78B

0.65%-610M

-1.30%-467M

8.23%-379M

Net business purchase and sale

----

-1,843.75%-837M

--0

---51M

----

190.57%48M

--0

----

Net investment purchase and sale

67.44%-28M

-251.52%-116M

-136.67%-71M

-80.95%-38M

33.90%79M

-109.76%-86M

65.63%-33M

56.52%-30M

80.56%-21M

-37.89%59M

Net other investing changes

-75.00%1M

0.00%22M

-75.00%2M

275.00%15M

-87.50%1M

100.00%4M

-15.38%22M

-33.33%8M

0.00%4M

33.33%8M

Cash from discontinued investing activities

Investing cash flow

8.01%-425M

-80.06%-3.13B

-30.38%-824M

-30.99%-634M

-359.47%-1.21B

-28.33%-462M

13.35%-1.74B

5.81%-632M

25.65%-484M

0.00%-264M

Financing cash flow

Cash flow from continuing financing activities

16.60%-1.18B

7.14%-7.09B

-40.84%-2.05B

-51.65%-2.34B

-58.55%-1.29B

63.12%-1.41B

-38.99%-7.64B

22.75%-1.46B

-12.06%-1.54B

35.68%-813M

Net issuance payments of debt

-202.38%-127M

-254.08%-2.48B

-9,490.00%-939M

-6,375.00%-1.51B

20.00%12M

94.35%-42M

-181.85%-699M

105.10%10M

135.82%24M

242.86%10M

Net common stock issuance

58.15%-226M

67.67%-1.23B

62.19%-259M

99.75%-2M

-8,420.00%-426M

76.59%-540M

-65.07%-3.8B

29.67%-685M

-37.82%-798M

98.94%-5M

Cash dividends paid

-7.53%-957M

-7.46%-3.56B

-7.90%-888M

-7.51%-888M

-7.49%-890M

-6.97%-890M

-3.34%-3.31B

-3.13%-823M

-3.12%-826M

-3.11%-828M

Proceeds from stock option exercised by employees

116.13%134M

0.00%167M

-17.07%34M

-1.75%56M

50.00%15M

5.08%62M

-34.51%167M

-50.00%41M

-18.57%57M

-41.18%10M

Cash from discontinued financing activities

Financing cash flow

16.60%-1.18B

7.14%-7.09B

-40.84%-2.05B

-51.65%-2.34B

-58.55%-1.29B

63.12%-1.41B

-38.99%-7.64B

22.75%-1.46B

-12.06%-1.54B

35.68%-813M

Net cash flow

Beginning cash position

-30.22%6.9B

0.85%9.88B

-30.07%6.71B

-12.33%7.84B

19.36%9.16B

0.85%9.88B

43.30%9.8B

3.14%9.59B

3.22%8.94B

-4.71%7.68B

Current changes in cash

20.99%-576M

-1,545.37%-2.96B

-31.65%162M

-245.68%-1.1B

-197.45%-1.3B

65.58%-729M

-93.24%205M

-53.53%237M

11.89%753M

122.17%1.33B

Effect of exchange rate changes

-550.00%-36M

81.15%-23M

-50.98%25M

69.79%-29M

61.97%-27M

233.33%8M

-74.29%-122M

492.31%51M

-231.03%-96M

-1,875.00%-71M

End cash Position

-31.40%6.28B

-30.22%6.9B

-30.07%6.71B

-12.33%7.84B

19.36%9.16B

0.85%9.88B

3.14%9.59B

3.22%8.94B

Free cash flow

-17.82%627M

-35.17%5.06B

33.04%2.28B

-43.06%1.32B

-65.73%696M

-56.25%763M

-9.76%7.8B

-30.04%1.72B

3.26%2.31B

18.43%2.03B

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-10.32%1.03B	-24.21%7.26B	30.61%3.04B	-32.48%1.88B	-50.08%1.2B	-44.65%1.14B	-9.04%9.58B	-24.16%2.33B	2.92%2.78B	13.25%2.41B
Net income from continuing operations	-7.06%1.23B	-17.45%5.72B	54.31%1.59B	0.07%1.44B	-31.86%1.38B	-46.14%1.32B	-1.95%6.93B	-48.06%1.03B	-31.67%1.44B	69.72%2.02B
Operating gains losses	----	-41.40%126M	----	----	----	----	290.91%215M	----	----	----
Depreciation and amortization	-0.12%805M	-0.73%3.24B	0.74%813M	1.10%824M	-2.68%800M	-2.07%806M	-7.66%3.27B	-8.61%807M	-3.78%815M	-5.95%822M
Other non cash items	30.48%-748M	----	----	-352.11%-179M	-817.39%-660M	-424.88%-1.08B	----	----	291.89%71M	194.85%92M
Change In working capital	-201.61%-561M	-62.94%-2.48B	-1,436.84%-1.52B	-195.54%-321M	33.13%-444M	85.75%-186M	-97.02%-1.52B	207.55%114M	204.02%336M	-2,313.33%-664M
-Change in receivables	-164.81%-151M	-423.53%-356M	-80.06%68M	-186.98%-461M	-4.26%-196M	131.03%233M	82.25%-68M	280.42%341M	234.52%530M	-637.14%-188M
-Change in inventory	2.15%-410M	83.58%-232M	256.08%295M	172.16%140M	47.90%-248M	24.37%-419M	-209.87%-1.41B	-1,360.00%-189M	-373.24%-194M	-9,420.00%-476M
-Change in prepaid assets	----	-622.67%-542M	----	----	----	----	75.96%-75M	----	----	----
-Change in payables and accrued expense	----	-280.95%-760M	----	----	----	----	-67.39%420M	----	----	----
-Change in other working capital	----	-52.74%-585M	----	----	----	----	57.82%-383M	----	----	----
Cash from discontinued investing activities
Operating cash flow	-10.32%1.03B	-24.21%7.26B	30.61%3.04B	-32.48%1.88B	-50.08%1.2B	-44.65%1.14B	-9.04%9.58B	-24.16%2.33B	2.92%2.78B	13.25%2.41B
Investing cash flow
Cash flow from continuing investing activities	8.01%-425M	-80.06%-3.13B	-30.38%-824M	-30.99%-634M	-359.47%-1.21B	-28.33%-462M	13.35%-1.74B	5.81%-632M	25.65%-484M	0.00%-264M
Net PPE purchase and sale	-4.74%-398M	-23.92%-2.2B	-23.77%-755M	-19.91%-560M	-33.77%-507M	-18.38%-380M	5.73%-1.78B	0.65%-610M	-1.30%-467M	8.23%-379M
Net business purchase and sale	----	-1,843.75%-837M	--0	---51M	----	----	190.57%48M	--0	--0	----
Net investment purchase and sale	67.44%-28M	-251.52%-116M	-136.67%-71M	-80.95%-38M	33.90%79M	-109.76%-86M	65.63%-33M	56.52%-30M	80.56%-21M	-37.89%59M
Net other investing changes	-75.00%1M	0.00%22M	-75.00%2M	275.00%15M	-87.50%1M	100.00%4M	-15.38%22M	-33.33%8M	0.00%4M	33.33%8M
Cash from discontinued investing activities
Investing cash flow	8.01%-425M	-80.06%-3.13B	-30.38%-824M	-30.99%-634M	-359.47%-1.21B	-28.33%-462M	13.35%-1.74B	5.81%-632M	25.65%-484M	0.00%-264M
Financing cash flow
Cash flow from continuing financing activities	16.60%-1.18B	7.14%-7.09B	-40.84%-2.05B	-51.65%-2.34B	-58.55%-1.29B	63.12%-1.41B	-38.99%-7.64B	22.75%-1.46B	-12.06%-1.54B	35.68%-813M
Net issuance payments of debt	-202.38%-127M	-254.08%-2.48B	-9,490.00%-939M	-6,375.00%-1.51B	20.00%12M	94.35%-42M	-181.85%-699M	105.10%10M	135.82%24M	242.86%10M
Net common stock issuance	58.15%-226M	67.67%-1.23B	62.19%-259M	99.75%-2M	-8,420.00%-426M	76.59%-540M	-65.07%-3.8B	29.67%-685M	-37.82%-798M	98.94%-5M
Cash dividends paid	-7.53%-957M	-7.46%-3.56B	-7.90%-888M	-7.51%-888M	-7.49%-890M	-6.97%-890M	-3.34%-3.31B	-3.13%-823M	-3.12%-826M	-3.11%-828M
Proceeds from stock option exercised by employees	116.13%134M	0.00%167M	-17.07%34M	-1.75%56M	50.00%15M	5.08%62M	-34.51%167M	-50.00%41M	-18.57%57M	-41.18%10M
Cash from discontinued financing activities
Financing cash flow	16.60%-1.18B	7.14%-7.09B	-40.84%-2.05B	-51.65%-2.34B	-58.55%-1.29B	63.12%-1.41B	-38.99%-7.64B	22.75%-1.46B	-12.06%-1.54B	35.68%-813M
Net cash flow
Beginning cash position	-30.22%6.9B	0.85%9.88B	-30.07%6.71B	-12.33%7.84B	19.36%9.16B	0.85%9.88B	43.30%9.8B	3.14%9.59B	3.22%8.94B	-4.71%7.68B
Current changes in cash	20.99%-576M	-1,545.37%-2.96B	-31.65%162M	-245.68%-1.1B	-197.45%-1.3B	65.58%-729M	-93.24%205M	-53.53%237M	11.89%753M	122.17%1.33B
Effect of exchange rate changes	-550.00%-36M	81.15%-23M	-50.98%25M	69.79%-29M	61.97%-27M	233.33%8M	-74.29%-122M	492.31%51M	-231.03%-96M	-1,875.00%-71M
End cash Position	-31.40%6.28B	-30.22%6.9B	-30.22%6.9B	-30.07%6.71B	-12.33%7.84B	19.36%9.16B	0.85%9.88B	0.85%9.88B	3.14%9.59B	3.22%8.94B
Free cash flow	-17.82%627M	-35.17%5.06B	33.04%2.28B	-43.06%1.32B	-65.73%696M	-56.25%763M	-9.76%7.8B	-30.04%1.72B	3.26%2.31B	18.43%2.03B
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall